Request Legal Help Now - Free
LAWSUITS NEWS & LEGAL INFORMATION

Drugs/Medical Legal News Articles & Interviews

View Lawyer Interviews only

New Research: Brief Heat Exposure Increases Zantac Cancer Odds

New Research: Brief Heat Exposure Increases Zantac Cancer Odds January 14, 2020. By Anne Wallace.
Washington, DC Emery Pharma, a California-based testing laboratory has reported that Zantac appears to produce unacceptably high levels of cancer-causing N-Nitrosodimethylamine (NDMA) when exposed to heat for as little as five days. Brief periods of modestly inadequate temperature control can easily occur during transport, storage or even in consumer’s home. These findings have sparked new calls for a U.S. Food and Drug Administration recall of Zantac and related generic drugs and will likely fuel class action Zantac cancer lawsuits (ZANTAC) already underway.
Read [ New Research: Brief Heat Exposure Increases Zantac Cancer Odds ]

More Ranitidine Cancer Concerns Lead to Zantac Lawsuits

More Ranitidine Cancer Concerns Lead to Zantac Lawsuits January 9, 2020. By Jane Mundy.
Santa Clara, CA Since the FDA last September reported that minute amounts of a carcinogen called N-nitrosodimethylamine (NDMA) was detected in Zantac, along with several other heartburn medications, a number of Zantac cancer lawsuits have followed.
Read [ More Ranitidine Cancer Concerns Lead to Zantac Lawsuits ]

Zantac – Buyer Beware, but from Whom?

Zantac – Buyer Beware, but from Whom? December 9, 2019. By Jane Mundy.
Santa Clara, CA Since the small pharmacy Valisure waved the red flag over Zantac cancer risk, over 40 countries worldwide have stopped sales and/or began investigating the possible health risks of the heartburn drug. And Zantac lawsuits have followed. Now the FDA says it is “investigating”.
Read [ Zantac – Buyer Beware, but from Whom? ]

More Zantac Cancer Lawsuits and Recalls

More Zantac Cancer Lawsuits and Recalls November 19, 2019. By Jane Mundy.
Santa Clara, CA As more pharmaceutical companies are hit with Zantac cancer lawsuits, they are recalling the acid reflux medication in the U.S. and Canada over complaints of a link to a probable carcinogen called called N-nitrosodimethylamine (NDMA), a chemical that has already been found in animals.
Read [ More Zantac Cancer Lawsuits and Recalls ]

Has J&J Lost Its Way?

Has J&J Lost Its Way? October 25, 2019. By Jane Mundy.
Philadelphia, PA: One of thousands of Risperdal cases pending in the Philadelphia court system has resulted in a whopping $8 billion in damages awarded to a single plaintiff who claimed he developed breasts, a condition known as gynecomastia. Plaintiff Nicholas Murray’s lawyers told the jury following the verdict that, “Johnson and Johnson is a company which has lost its way.”
Read [ Has J&J Lost Its Way? ]

Health Canada in Gadolinium Denial

Health Canada in Gadolinium Denial September 13, 2019. By Jane Mundy.
Fort Saskatchewan, AB: How can a heavy metal accumulate in the brain but not be considered harmful? After undergoing seven MRI scans, all with injections of a gadolinium-based contrast agent (GBCA), Wanda Milley experienced the same gadolinium contrast dye side effects that many other patients have suffered, and have subsequently filed gadolinium lawsuits.
Read [ Health Canada in Gadolinium Denial ]

What’s Next for Ethicon Hernia Mesh Lawsuits?

What’s Next for Ethicon Hernia Mesh Lawsuits? September 12, 2019. By Anne Wallace.
Atlanta, GA Judge Richard W. Story has now identified ten bellwether Ethicon Physiomesh lawsuits that will likely shape the multidistrict litigation pending in the U.S. District Court, Northern District of Georgia. Trials in these hernia mesh lawsuits are now scheduled to begin in April 2020. But there will be plenty to watch even before opening statements begin.
Read [ What’s Next for Ethicon Hernia Mesh Lawsuits? ]

Gadolinium Dyeing Out?

Gadolinium Dyeing Out? August 13, 2019. By Jane Mundy.
Buffalo, NY: Many reports of adverse side events associated with gadolinium contrast dye, along with recent data showing that gadolinium deposits in the brain and other organs have spurred researchers to find imaging approaches that don’t need gadolinium-based contrast agents (GBCAs).
Read [ Gadolinium Dyeing Out? ]

Lawmakers Suspect Gilead Has Ulterior Motives for Donating HIV/AIDS drug Truvada

Lawmakers Suspect Gilead Has Ulterior Motives for Donating HIV/AIDS drug Truvada July 25, 2019. By Jane Mundy.
Washington, DC:The drug manufacturer Gilead announced in May that it was making an annual donation of 2.4 million bottles of Truvada that is prescribed as a prophylactic to prevent the spread of HIV, also known as PrEP. Some lawmakers, however, suspect that the donation comes with strings attached.
Read [ Lawmakers Suspect Gilead Has Ulterior Motives for Donating HIV/AIDS drug Truvada ]

MRI with Gadolinium – Better to be Safe than Sorry?

MRI with Gadolinium – Better to be Safe than Sorry? June 19, 2019. By Jane Mundy.
Washington, DC: The FDA in December 2017 recommended that repeated use of MRIs with gadolinium contrast dye be minimized wherever possible, and when MRIs are taken closely together in particular. It’s like a Catch-22: an MRI can detect cancer but it can also pose certain risks -- is it better to be safe than sorry?
Read [ MRI with Gadolinium – Better to be Safe than Sorry? ]

Page: 1  2  3  4  5  6  7  8  9  -  10»  -  100»  -  124   Next»
Request Legal Help Now! - Free